Lillian W. Chiang, Ph.D., MBA
 Dr. Lillian Chiang is Founder and CEO of FORGE Life Science, LLC, an antiviral company dedicated to commercializing small molecule drugs for the treatment of virus-caused infectious diseases based on break-through discoveries made at Princeton University. The FORGE LS antiviral platform combines newly invented chemistries with recent biological insights into fundamental host-virus interactions; this drives completely new concepts in the control of viral infection. Lillian’s career has been dedicated to translating state-of-the-art bench science to affect patients in need; she has built from the ground up technologies, drug discovery & development teams, and businesses at Stanford, Millennium Pharmaceuticals, Purdue Pharma, Aestus Therapeutics, and most recently, Kadmon Corporation, where she was VP of Translational Medicine. BS, MIT; PhD, Wisconsin; MBA, Wharton.
|
|
